Vericel Corp: Form 10-Q for the period ended Sep 30, 2017
Filed with the SEC on Nov 7, 2017 and accepted by EDGAR at Nov 7, 2017, 09:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-07-01 to 2017-09-30 | $7.2m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2017-01-01 to 2017-09-30 | $22.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2017-07-01 to 2017-09-30 | $7.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2017-01-01 to 2017-09-30 | $18.6m | us-gaap:GrossProfit |
| Research and development | 3 months2017-07-01 to 2017-09-30 | $2.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2017-01-01 to 2017-09-30 | $9.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-07-01 to 2017-09-30 | $8.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2017-01-01 to 2017-09-30 | $25.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-07-01 to 2017-09-30 | −$4.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-01-01 to 2017-09-30 | −$16.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-07-01 to 2017-09-30 | $317.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2017-01-01 to 2017-09-30 | $878.0k | us-gaap:InterestExpense |
| Net income | 3 months2017-07-01 to 2017-09-30 | −$5.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-01-01 to 2017-09-30 | −$17.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-07-01 to 2017-09-30 | −$0.16 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2017-01-01 to 2017-09-30 | −$0.54 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2017-01-01 to 2017-09-30 | −$14.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2017-09-30 | $15.5m | us-gaap:Cash |
| Current assets | At period end2017-09-30 | $36.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-09-30 | $40.3m | us-gaap:Assets |
| Current liabilities | At period end2017-09-30 | $14.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-09-30 | $23.5m | us-gaap:Liabilities |
| Long-term debt | At period end2017-09-30 | $7.4m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2017-09-30 | $16.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-17-011022. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.